The simian immunodeficiency virus (SIV) mnd(GB-1) strain, isolated from a mandrill, replicates in a human T cell line, CEM cells, and is inhibited by the CXC-chemokines, stromal cell-derived factor 1α and 1β (SDF-1α/SDF-1β),the natural ligands for CXCR4. The IC50 was around 70–80 ng/ml, which corresponds to the IC50 of SDF-1α/SDF-1β for T-tropic human immunodeficiency virus type 1 (HIV-1) and HIV-2. The specific anti-CXCR4 MAb 12G5 inhibited replication of SIVmnd at an IC50 of 1 μg/ml. Also, the IC50 of 8 ng/ml for SIVmnd of the bicyclam AMD3100, a specific CXCR4 antagonist, is comparable with its IC50 for T-tropic HIV-1 and HIV-2 strains. Two other SIV strains, SIVagm3 and SIVmac251, were insensitive to SDF-1α/SDF-1β, anti-CXCR4 MAb and AMD3100. SIVmnd replicates only in HOS.CD4 cells expressing CXCR4 and not in HOS.CD4 transfectants expressing CCR1, CCR2b, CCR3, CCR4 or CCR5. This is, to our knowledge, the first SIV strain found to use CXCR4 and not CCR5 as a main coreceptor for entering human cells.
AlkhatibG.,
CombadiereC.,
BroderC. C.,
FengY.,
KennedyP. E.,
MurphyP. M.,
BergerE. A.1996; CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955–1958
BersonJ. F.,
LongD.,
DoranzB. J.,
RuckerJ.,
JirikF. R.,
DomsR. W.1996; A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type-1 strains. Journal of Virology 70:6288–6295
BleulC. C.,
FarzanM.,
ChoeH.,
ParolinC.,
Clark-LewisI.,
SodroskiJ.,
SpringerT. A.1996; The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829–832
ChenZ.,
ZhouP.,
HoD. D.,
LandauN. R.,
MarxP. A.1997; Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. Journal of Virology 71:2705–2714
CocchiF.,
DeVicoA. L.,
Garzino-DemoA.,
AryaS. K.,
GalloR. C.,
LussoP.1995; Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+T cells. Science 270:1811–1815
ConnorR. I.,
SheridanK. E.,
CeradiniD.,
ChoeS.,
LandauN. R.1997; Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. Journal of Experimental Medicine 185:621–628
De ClercqE.,
YamamotoN.,
PauwelsR.,
BabaM.,
ScholsD.,
NakashimaH.,
BalzariniJ.,
MurrerB. A.,
SchwartzD.,
ThorntonD.,
BridgerG.,
FrickerS.,
HensonG.,
AbramsM.,
PickerD.1992; Potent and selective inhibition of human immunodeficiency virus (HIV)- 1 and HIV-2 replication by a classof bicyclams interacting with a viral uncoating event. Proceedings of the National Academy of Sciences, USA 89:5286–5290
DengH.,
LiuR.,
EllmeierW.,
ChoeS.,
UnutmazD.,
BurkhartM.,
MarzioP. D.,
MarmonS.,
SuttonR. E.,
HillC. M.,
DavisC. B.,
PeiperS. C.,
SchallT. J.,
LittmanD. R.,
LandauN. R.1996; Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666
DengH.,
UnutmazD.,
KewalRamaniV. N.,
LittmanD. R.1997; Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296–300
De VreeseK.,
Kofler-MongoldV.,
LeutgebC.,
WeberV.,
VermeireK. ,
AnnéJ.,
De ClercqE.,
DatemaR.,
WernerG.1996; The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. Journal of Virology 70:689–696
DragicT.,
LitwinV.,
AllawayG. P.,
MartinS. R.,
HuangY.,
NagashimaK. A.,
CayananC.,
MaddonP. J.,
KoupR. A.,
MooreJ. P.,
PaxtonW. A.1996; HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673
EdingerA. L.,
AmedeeA.,
MillerK.,
DoranzB. J.,
EndresM.,
SharronM.,
SamsonM.,
LuZ. -H.,
ClementsJ. E.,
Murphy-CorbM.,
PeiperS. C.,
ParmentierM.,
BroderC. C.,
DomsR. W.1997; Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences, USA 94:4005–4010
FarzanM.,
ChoeH.,
MartinK.,
MarconL.,
HofmannW.,
KarlssonG.,
SunY.,
BarrettP.,
MarchandN.,
SullivanN.,
GerardN.,
GerardC.,
SodroskiJ.1997; Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simianimmunodeficiency virus infection. Journal of Experimental Medicine 186:405–411
HirschV. M.,
DapolitoG. A.,
GoldsteinS.,
McClureH.,
EmauP.,
FultzP. N.,
IsahakiaM.,
LenrootR.,
MyersG.,
JohnsonP. R.1993; A distinct lentivirus from Sykes´ monkeys. Journal of Virology 67:1517–1528
LiaoF.,
AlkhatibG.,
PedenK. W. C.,
SharmaG.,
BergerE. A.,
FarberJ. M.1997; STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line- tropic HIV-1. Journal of Experimental Medicine 185:2015–2023
LuZ. -H.,
BersonJ. F.,
ChenY. -H.,
TurnerJ. D.,
ZhangT. -Y.,
SharronM.,
JenksM. H.,
WangZ. -X.,
KimJ.,
RuckerJ.,
HoxieJ. A.,
PeiperS. C.,
DomsR. W.1997; Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proceedings of the National Academy of Sciences, USA 94:6426–6431
MarconL.,
ChoeH.,
MartinK. A.,
FarzanM.,
PonathP. D.,
WuL.,
NewmanW.,
GerardN.,
GerardC.,
SodroskiJ.1997; Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. Journal of Virology 71:2522–2527
McKnightA.,
WilkinsonD.,
SimmonsG.,
TalbotS.,
PicardL.,
AhujaM.,
MarshM.,
HoxieJ. A.,
ClaphamP. R.1997; Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. Journal of Virology 71:1692–1696
OberlinE.,
AmaraA.,
BachelerieF.,
BessiaC.,
VirelizierJ. L.,
Arenzana-SeisdedosF.,
SchwartzO.,
HeardJ. M.,
Clark-LewisI.,
LeglerD. F.,
LoetscherM.,
BaggioliniM.,
MoserB.1996; The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833–835
PleskoffO.,
TrébouteC.,
BrelotA.,
HevekerN.,
SemanM.,
AlizonM.1997; Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276:1874–1878
ScholsD.,
EstéJ. A.,
Henson,G.,
De ClercqE.1997a; Bicyclams,a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral Research 35:147–156
ScholsD.,
StruyfS.,
Van DammeJ.,
EstéJ. A.,
HensonG.,
De ClercqE.1997b; Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. Journal of Experimental Medicine 186:1383–1388